Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - LONG-TERM DEBT
Long-term Debt KALV - KalVista Pharmaceuticals, Inc.
6.02 M
LAST VALUE
-8.67%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR